In welcome news for patients like McNabb, was approved by the U.S . Food and Drug Administration the use of Avastin last month for the treatment of brain tumors. The powerful drug shrinks tumors by choking their blood supply. Half of the patients do not respond to therapy, which unnecessary side effects unnecessary side effects and medications up to $ 10,000 per month. The finding presents clear clinical benefits for the patient, says Pope ‘With this information ahead of time will help doctors personalize therapy for each patient and decrease exposure to side effects, ‘he noted. – Pope and his colleagues plan to confirm their findings in a larger study, the team will also test the new method ‘s ability to identify responders prior to surgical removal of the tumor. Despite therapy with surgery, radiation and chemotherapy, funded the research. Average glioblastoma patients only 12 to 15 months after diagnosis. Survival rates drop even lower if the tumor returns. Conventional therapies produce little benefit, only 8 to 15 % of patients survive without tumor progression 6 months after the treatment.

click to see full text

Bradley Hasbro Children Research Center Hasbro pediatric hospital researchers more than $ 2,000 receive in direct costs by The Eunice Kennedy Shriver nation Institute of Child Health and Human Development to study the impact of asthma on the sleep quality and academic performance of children.